{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:22:56Z","timestamp":1794248576663,"version":"4.9.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204536"],"award-info":[{"award-number":["82204536"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.isci.2026.116862","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:58:43Z","timestamp":1784840323000},"page":"116862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["GSK3B variations influence renoprotective responses to dapagliflozin in diabetic kidney disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Jinfang","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongru","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjiang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116862_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2315607","article-title":"Prevalence of Diabetic Nephropathy among Patients with Type 2 Diabetes Mellitus in China: A Meta-Analysis of Observational Studies","volume":"2020","author":"Zhang","year":"2020","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.isci.2026.116862_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.116862_bib3","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in Patients with Chronic Kidney Disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.116862_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s13410-021-00967-z","article-title":"Effect of constructing doctor-pharmacist joint pharmacy clinic for outpatients on the comprehensive management of type 2 diabetes mellitus: a pilot RCT","volume":"42","author":"Song","year":"2022","journal-title":"Int. J. Diabetes Dev. Ctries."},{"key":"10.1016\/j.isci.2026.116862_bib5","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.2337\/dc21-S009","article-title":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.isci.2026.116862_bib6","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/dom.13579","article-title":"Reduction in albuminuria with dapagliflozin cannot be predicted by baseline clinical characteristics or changes in most other risk markers","volume":"21","author":"Heerspink","year":"2019","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.isci.2026.116862_bib7","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/dom.12936","article-title":"The albuminuria-lowering response to dapagliflozin is variable and reproducible among individual patients","volume":"19","author":"Petrykiv","year":"2017","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.isci.2026.116862_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12920-021-01108-5","article-title":"PPARD rs2016520 (T\/C) and NOS1AP rs12742393 (A\/C) polymorphisms affect therapeutic efficacy of nateglinide in Chinese patients with type 2 diabetes mellitus","volume":"14","author":"Wang","year":"2021","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.isci.2026.116862_bib9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/1389200220666190111114146","article-title":"Effects of CYP2C8 and SLCO1B1 Genetic Polymorphisms on Repaglinide Pharmacokinetics: A Systematic Review and Meta-Analysis","volume":"20","author":"Zhou","year":"2019","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.isci.2026.116862_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1440-1681.12314","article-title":"PPARD rs2016520 polymorphism affects repaglinide response in Chinese Han patients with type 2 diabetes mellitus","volume":"42","author":"Song","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.isci.2026.116862_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/cpt.1651","article-title":"The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later","volume":"107","author":"Relling","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.isci.2026.116862_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.116862_bib13","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1074\/mcp.RA118.000752","article-title":"Butyrate Suppresses the Proliferation of Colorectal Cancer Cells via Targeting Pyruvate Kinase M2 and Metabolic Reprogramming","volume":"17","author":"Li","year":"2018","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.isci.2026.116862_bib14","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/dom.12654","article-title":"Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin-angiotensin blockers","volume":"18","author":"Heerspink","year":"2016","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.isci.2026.116862_bib15","doi-asserted-by":"crossref","first-page":"F184","DOI":"10.1152\/ajprenal.00043.2017","article-title":"Urinary adenosine excretion in type 1 diabetes","volume":"313","author":"Rajasekeran","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.isci.2026.116862_bib16","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1002\/ptr.7943","article-title":"Targeting HSP90 with picropodophyllin suppresses gastric cancer tumorigenesis by disrupting the association of HSP90 and AKT","volume":"37","author":"Li","year":"2023","journal-title":"Phytother Res."},{"key":"10.1016\/j.isci.2026.116862_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114798","article-title":"Drug affinity responsive target stability (DARTS) accelerated small molecules target discovery: Principles and application","volume":"194","author":"Ren","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.isci.2026.116862_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/1087057106296047","article-title":"Three mechanistically distinct kinase assays compared: Measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors","volume":"12","author":"Kashem","year":"2007","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.isci.2026.116862_bib19","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2014020192","article-title":"EGF receptor deletion in podocytes attenuates diabetic nephropathy","volume":"26","author":"Chen","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2026.116862_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1021\/acs.jproteome.4c00751","article-title":"Development of a Multiplexed LC-MS\/MS Assay for the Quantitation of Podocyte Injury Biomarkers Nephrin, Podocalyxin, and Podocin in Human Urine","volume":"24","author":"Morales-Betanzos","year":"2025","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.isci.2026.116862_bib21","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.2337\/diabetes.52.12.2969","article-title":"Nephrinuria in diabetic nephropathy of type 1 diabetes","volume":"52","author":"P\u00e4t\u00e4ri","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.isci.2026.116862_bib22","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.celrep.2015.06.056","article-title":"Diet-Induced Podocyte Dysfunction in Drosophila and Mammals","volume":"12","author":"Na","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.116862_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/10.1.1","article-title":"The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death","volume":"10","author":"Putaala","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.isci.2026.116862_bib24","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1681\/ASN.2020050572","article-title":"Synaptopodin Is Dispensable for Normal Podocyte Homeostasis but Is Protective in the Context of Acute Podocyte Injury","volume":"31","author":"Ning","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2026.116862_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156314","article-title":"Phillygenin improves diabetic nephropathy by inhibiting inflammation and apoptosis via regulating TLR4\/MyD88\/NF-\u03baB and PI3K\/AKT\/GSK3\u03b2 signaling pathways","volume":"136","author":"Feng","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.isci.2026.116862_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2003308","article-title":"Phosphoinositide 3-kinase \u03b3 inhibits cardiac GSK-3 independently of Akt","volume":"6","author":"Mohan","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.isci.2026.116862_bib27","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.3390\/ijms22073798","article-title":"Cannabidiol and the Canonical WNT\/\u03b2-Catenin Pathway in Glaucoma","volume":"22","author":"Vall\u00e9e","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.116862_bib29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41401-020-0450-2","article-title":"Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy","volume":"42","author":"Du","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.isci.2026.116862_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114675","article-title":"Sarsasapogenin restores podocyte autophagy in diabetic nephropathy by targeting GSK3\u03b2 signaling pathway","volume":"192","author":"Li","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.isci.2026.116862_bib31","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1039\/D2FO00940D","article-title":"Sodium butyrate ameliorated diabetic nephropathy-associated tubulointerstitial inflammation by modulating the tight junctions of renal tubular epithelial cells","volume":"15","author":"Yang","year":"2024","journal-title":"Food Funct."},{"key":"10.1016\/j.isci.2026.116862_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12902-025-01960-x","article-title":"Case-control study combined with machine learning techniques to identify key genetic variations in GSK3B that affect susceptibility to diabetic kidney diseases","volume":"25","author":"Song","year":"2025","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.isci.2026.116862_bib32","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1038\/s12276-024-01357-1","article-title":"The anticancer effect of metformin targets VDAC1 via ER-mitochondria interactions-mediated autophagy in HCC","volume":"56","author":"Ko","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.isci.2026.116862_bib33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00210-017-1445-5","article-title":"Sarsasapogenin suppresses A beta overproduction induced by high glucose in HT-22 cells","volume":"391","author":"Zhang","year":"2018","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.isci.2026.116862_bib34","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ptr.6088","article-title":"Protective effects of sarsasapogenin against early stage of diabetic nephropathy in rats","volume":"32","author":"Liu","year":"2018","journal-title":"Phytother Res."},{"key":"10.1016\/j.isci.2026.116862_bib35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ptr.5254","article-title":"Mangiferin attenuates renal fibrosis through down-regulation of osteopontin in diabetic rats","volume":"29","author":"Zhu","year":"2015","journal-title":"Phytother Res."},{"key":"10.1016\/j.isci.2026.116862_bib36","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41467-019-08424-6","article-title":"Quantification of frequency-dependent genetic architectures in 25 UK Biobank traits reveals action of negative selection","volume":"10","author":"Schoech","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116862_bib37","article-title":"Variants in PPARD-GLP1R are related to diabetic kidney disease in Chinese Han patients with type 2 diabetes mellitus","volume":"10","author":"Song","year":"2024","journal-title":"Heliyon"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226022406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226022406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:54:33Z","timestamp":1794246873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226022406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2589004226022406"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116862","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GSK3B variations influence renoprotective responses to dapagliflozin in diabetic kidney disease","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116862"}}